Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |